BioSpace News Archive

Shield Diagnostics, an Andreessen Horowitz-backed clinical laboratory tackling antibiotic resistance by bringing precision medicine to infectious disease, announced the launch of Target-NG, a rapid molecular test for antibiotic susceptibility in Neisseria gonorrhoeae.

Bipartisan, bicameral legislation will bring equality to insurance coverage of life-saving medicines

Pomerantz LLP is investigating claims on behalf of investors of Corbus Pharmaceuticals Holdings, Inc. (“Corbus” or the “Company”) (NASDAQ: CRBP). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.

SynergEyes, Inc., a leader in specialty contact lens technology, announces that the SynergEyes VS scleral lens is now available with Tangible Hydra-PEG on Contamac material

The Honourable Marie-Claude Bibeau, Minister of Agriculture and Agri-Food, will announce measures taken by the Government of Canada to help prevent the introduction of African swine fever into Canada.

Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that former Kansas City Chiefs Offensive Lineman John Alt has joined as their newest spokesperson for its subsidiary Kannaway® to help spread awareness on the benefits of hemp cannabidiol (CBD) for athletes and active consumers.

GHP Magazine has awarded MMS Holdings Most Outstanding Global CRO in the 2019 Biotechnology Awards.

Walgreens Flu Index for Week Ending March 9, 2019

Collaboration builds on success of hip replacement program launched in 2018

This Revolutionary Diagnostic Provides Unique Information for Accessing Coagulation at the Point of Care; Now Commercially Available in US